Short periods of physical movement are getting attention because many people have little time for long exercise sessions. Busy schedules and sedentary jobs make it harder to meet traditional activity goals, so people look for simpler ways to be active.
Stella Volpe of Virginia Tech answered questions about short bursts of movement. The available excerpt says such intermittent activity can have positive effects, and the overall message may be encouraging. However, the report is brief and does not give specific recommendations.
The excerpt does not list exact durations, frequency, intensity, or which health measures improve. Readers should consult the full Futurity piece or the expert for complete guidance.
Difficult words
- intermittent — happening in short, separate times
- sedentary — sitting a lot with little movement
- intensity — how strong or hard an activity is
- frequency — how often an activity or event happens
- recommendation — advice about what to dorecommendations
- excerpt — a short part taken from a longer text
- schedule — plans for when to do activitiesschedules
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you have a busy schedule that makes exercise hard? Give one example.
- Would short bursts of movement fit into your day? Why or why not?
- Would you read the full article or ask the expert for more details? Why?
Related articles
Genes linked to chronic kidney disease
Researchers led by Alejandro Chade at the University of Missouri studied genes involved in chronic kidney disease using animal models. They found genes linked to kidney damage; silencing one gene lowered fibrosis. The team will map and test gene activity.
Western Pacific priorities as WHO adapts after US withdrawal
WHO regional director Saia Maʻu Piukala outlines challenges and priorities for the Western Pacific as the organisation adapts after the US withdrawal. Key events include the World Health Summit in Berlin (12–14 October) and the Fiji Regional Committee (20–24 October 2025).
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.